AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for mesothelioma

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites๐Ÿ“ Santa Rosa๐Ÿ“ Hartford๐Ÿ“ Washington D.C. VM Oncology, LLC ยท Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) PTC-Guided Therapy for Peritoneal Mesothelioma NCT07330271NA1 site๐Ÿ“ Beijing Beijing Tsinghua Chang Gung Hospital ยท Tests: PTC guided individualized treatment, Standard chemotherapy regimens A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab dENdritic Cell Therapy Combined With SURgEry in Mesothelioma NCT05304208Phase 11 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Mesopher Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors NCT06535607Phase 298 sites๐Ÿ“ Los Angeles๐Ÿ“ Baltimore๐Ÿ“ New York AstraZeneca ยท Tests: Volrustomig, Cisplatin, Carboplatin, Paclitaxel, 5-FU A 2-part Phase 1/2 Open-label Trial on ODM-212 NCT07563738Phase 1, Phase 223 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Fort Worth Orion Corporation, Orion Pharma ยท Tests: ODM-212, Ipilimumab and nivolumab, Gemcitabine and nab-paclitaxel, sotorasib A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Nurix Therapeutics, Inc. ยท Tests: NX-1607, Paclitaxel First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies NCT05627960Phase 11 site๐Ÿ“ Baltimore A&G Pharmaceutical Inc. ยท Tests: AG-01 Compound Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site๐Ÿ“ Chicago University of Chicago ยท Tests: Partial Pleurectomy Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma NCT07234058Phase 237 sites๐Ÿ“ Aix-en-Provence๐Ÿ“ Amiens๐Ÿ“ Angers Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Cemiplimab, Fianlimab, Pemetrexed (Alimta), Cisplatin, Carboplatin (AUC 5) Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma NCT05001880Phase 241 sites๐Ÿ“ Phoenix๐Ÿ“ Chicago๐Ÿ“ Chicago National Cancer Institute (NCI) ยท Tests: Atezolizumab, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography SW-682 in Advanced Solid Tumors NCT06251310Phase 18 sites๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles๐Ÿ“ Sacramento SpringWorks Therapeutics, Inc., a healthcare company of Merโ€ฆ ยท Tests: SW-682, Combination Therapy Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy NCT06840834Phase 221 sites๐Ÿ“ Besanรงon๐Ÿ“ Brest๐Ÿ“ Caen Intergroupe Francophone de Cancerologie Thoracique ยท Tests: Ivonescimab TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites๐Ÿ“ Camperdown๐Ÿ“ Malvern๐Ÿ“ Nedlands Treeline Biosciences, Inc. ยท Tests: TLN-499, Venetoclax Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed NCT01617382n/a1 site๐Ÿ“ Leuven Universitaire Ziekenhuizen KU Leuven Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai๐Ÿ“ Chengdu Ruijin Hospital ยท Tests: Ivonescimab Combined With Chemotherapy Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500Phase 125 sites๐Ÿ“ Phoenix๐Ÿ“ Lone Tree๐Ÿ“ Jacksonville Bristol-Myers Squibb ยท Tests: MRTX1719 First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis. NCT06946498NA1 site๐Ÿ“ Athens National and Kapodistrian University of Athens ยท Tests: Local Anesthesia Thoracoscopy, Pleuroscopy with Rigid Thoracoscope and Forceps biopsies Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) NCT03760575Phase 11 site๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine ยท Tests: Pembrolizumab, Indocyanine Green (ICG) Image-Guided Surgery, Cisplatin, Pemetrexed GPC3/Mesothelin-CAR-ฮณฮดT Cells Against Cancers NCT06196294Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Cell therapy for solid tumors A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma NCT06623396Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: M28z1XXPD1DNR CAR Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease NCT07192900Phase 11 site๐Ÿ“ Pittsburgh David Bartlett, MD ยท Tests: locally manufactured adoptive cellular therapy (ACT) product, Interleukin-2 Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma NCT06875076Phase 21 site๐Ÿ“ Changchun The First Hospital of Jilin University ยท Tests: Ivonescimab Combined With Chemotherapy Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors NCT07443020Phase 11 site๐Ÿ“ Pittsburgh Allegheny Singer Research Institute (also known as Alleghenโ€ฆ ยท Tests: locally manufactured adoptive cellular therapy (ACT) product, Interleukin-2 (IL-2) INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630NA2 sites๐Ÿ“ Palermo๐Ÿ“ Perugia Azienda Ospedaliero-Universitaria di Parma ยท Tests: Functional tests, Multi-omics analyses, Cytogenetics/ FISH MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI NCT05730816Phase 21 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Magnesium sulfate, Normal Saline Stereotactic Magnetic Resonance Guided Radiation Therapy NCT04115254NA2 sites๐Ÿ“ Boston๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: MR-guided Linac Lead-212 PSV359 Therapy for Patients With Solid Tumors NCT06710756Phase 1, Phase 216 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Miami Perspective Therapeutics ยท Tests: [203Pb]Pb-PSV359, [212Pb]Pb-PSV359 A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors NCT06452160Phase 11 site๐Ÿ“ Houston BridGene Biosciences Inc. ยท Tests: BGC515
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy